Arcutis Biotherapeutics, Inc. (ARQT)
29.80
-1.23
(-3.96%)
USD |
NASDAQ |
Dec 09, 12:01
Arcutis Biotherapeutics Shareholders Equity (Quarterly): 158.07M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 431.19M |
| ANI Pharmaceuticals, Inc. | 505.82M |
| CorMedix, Inc. | 374.13M |
| Editas Medicine, Inc. | 13.45M |
| Syndax Pharmaceuticals, Inc. | 115.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 370.98M |
| Total Liabilities (Quarterly) | 212.90M |
| Debt to Equity Ratio | 0.7198 |
| Current Ratio | 3.500 |
| Net Debt Paydown Yield | 0.83% |